D

Dexcare

Recent signal 🇺🇸 United States · Health
Latest round
Funded
3 days ago
Open roles
1
1 posted in the last 30 days
Backed by
1 investor
ICONIQ Growth
Hiring now

Open roles at Dexcare

1 live role, newest first
Vice President AI/ ML
Bengaluru 11 Sep 2026
Apply →
Why join

Latest Dexcare Signals

What they do

DexCare has acquired Mila Health to expand its AI care coordination platform, enhancing its capabilities in patient scheduling and follow-up. Financial terms of the transaction were not disclosed, but this acquisition marks a strategic move to integrate Mila's AI agents into DexCare's existing framework, which has already facilitated over 10 million bookings.

Why it matters

DexCare's platform combines scheduling data, workflows, and institutional knowledge into a governed system, allowing AI agents to manage complex patient journeys. Mila's agents utilize this access data model to streamline appointment scheduling, follow-ups, and patient outreach, significantly improving operational efficiency.

Traction

DexCare serves healthcare organizations across all 50 states, reaching 57 million patients. The company has codified 260 scheduling policies for clients like Tampa General Hospital and has previously raised $146 million, including a $75 million Series C round led by ICONIQ Growth in 2023.

Where the market is going

DexCare is positioning itself against traditional scheduling solutions that falter under complex clinical requirements. By integrating AI with a robust data model, it addresses the inefficiencies of manual call centers and outdated systems, setting a new standard for patient care coordination in a fragmented healthcare landscape.

Backed by
ICONIQ Growth
Analysis updated 2 Oct 2026 Full deal history on MapCo →